PubMed=24502583; DOI=10.1186/1757-2215-7-17; PMCID=PMC4015880
Brueggmann D., Templeman C., Starzinski-Powitz A., Rao N.P., Gayther S.A., Lawrenson K.
Novel three-dimensional in vitro models of ovarian endometriosis.
J. Ovarian Res. 7:17.1-17.11(2014)

PubMed=24972189; DOI=10.1016/j.ygyno.2014.06.016
Lawrenson K., Lee N., Torres H.A.M., Lee J.M., Brueggmann D., Rao P.N., Noushmehr H., Gayther S.A.
Src as a novel therapeutic target for endometriosis.
Gynecol. Oncol. 135:100-107(2014)

PubMed=25804953; DOI=10.1093/hmg/ddv101; PMCID=PMC4459387
Coetzee S.G., Shen H.C., Hazelett D.J., Lawrenson K., Kuchenbaecker K., Tyrer J.P., Rhie S.K., Levanon K., Karst A.M., Drapkin R.I., Ramus S.J., Couch F.J., Offit K., Chenevix-Trench G., Monteiro A.N.A., Antoniou A., Freedman M.L., Coetzee G.A., Pharoah P.D.P., Noushmehr H., Gayther S.A.
Consortium of Investigators of Modifiers of BRCA1/2
Ovarian Cancer Association Consortium
Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci.
Hum. Mol. Genet. 24:3595-3607(2015)

PubMed=32106286; DOI=10.1093/humrep/dez266; PMCID=PMC7048714
Romano A., Xanthoulea S., Giacomini E., Delvoux B., Alleva E., Vigano P.
Endometriotic cell culture contamination and authenticity: a source of bias in in vitro research?
Hum. Reprod. 35:364-376(2020)